ArticleThe Journal of clinical investigation2017

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.

Carlos A Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.